MedTrace Logo

The Validity and Reliability of the Turkish Version of the Combined Index of Severity of Fibromyalgia

NCT03800199 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-08-16

No results posted yet for this study

Summary

The aim of the investigator's study is to determine the validity and reliability of the Turkish version of the Combined Index of Severity (ICAF) in Turkish patients with Fibromyalgia Syndrome (FMS).

Conditions

  • Fibromyalgia

Interventions

OTHER

Perceptive rehabilitation

The first session will be an education session. Spinous processes will be reference line of the body and patient will lie down on cones. The therapist will ask the patient first to breathe normally and feel the pressure. This will lead the patient to relax and understand cones. Then, the patient will start with the diagrammatic breathing. After breath exercises patient will perform active exercises (include stretching, warming up and cooling down) on supervision. Exercises will include the whole body. Additional to this during the session therapist will ask about the pressure of cones and she will correct the patients' posture. At the end of all the session, the therapist will take a photo of the patients back with the aim of to document the pressure and hyperaemic areas.

Sponsors & Collaborators

  • European University of Lefke

    lead OTHER

Principal Investigators

  • Beraat Alptug, MSc · European University of Lefke

  • Emine H. Tüzün, Prof. Dr. · Eastern Mediterranean University

  • Levent Eker, M. D. · Eastern Mediterranean University

  • Gülbin Ergin, PhD · European University of Lefke

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-13
Primary Completion
2024-06-30
Completion
2024-07-31

Countries

  • Cyprus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03800199 on ClinicalTrials.gov